脏缺血改善心脏功能和运动时间在心力衰竭的迷你猪模型中,保留了喷射分数
David J Lefer1, Thomas E Sharp2, Amy L Scarborough3
1Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
European journal of heart failure
|May 22, 2025
概括
脏缺血 (RDN) 在心力衰竭中改善了心脏透析功能和运动耐受性,并保留了喷射分数 (HFpEF) 迷你猪模型. 这表明RDN可能是对HFpEF进展的潜在治疗方法.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医疗器械 医疗器械
背景情况:
- 交感神经系统过度活跃是心力衰竭的关键,伴随着保留喷射分数 (HFpEF) 的并发症.
- 导管式脏缩 (RDN) 有效地治疗高血压和心力衰竭中的心脏功能障碍,减少排泄率.
- 为心脏代谢HFpEF建立了一个临床相关的小猪模型.
研究的目的:
- 在HFpEF的迷你猪模型中评估RDN是否改善心脏功能和运动耐受性.
- 评估调节交感神经活动对HFpEF参数的影响.
主要方法:
- 在哥廷根的小猪中,HFpEF被诱导,使用过多的矿物质皮质醇和特定的饮食.
- 动物被随机分配到以导管为基础的RDN或假冒程序.
- 评估了脏交感活动,心脏功能,运动耐受性和血液动力学.
主要成果:
- 在HFpEF小型猪中,RDN显著降低了交感活动,并增加了运动持续时间.
- 在RDN后观察到透缩功能 (E / e,左心房分数面积变化) 的持续改善.
- RDN没有影响左心室填充率和肺压的升高,但暂时降低了血压.
结论:
- 基于设备的RDN显示了阻止HFpEF进展的潜力.
- 在HFpEF中,RDN可能会改善心脏扩张功能和运动能力.
- 需要进一步研究RDN作为HFpEF治疗策略.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
01:22Heart Failure Drugs: Diuretics
313
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
313
01:22Heart Failure Drugs: β-Blockers
300
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
300